Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.058 USD | -1.69% | -1.69% | +78.46% |
Valuation
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Capitalization 1 | 105.9 | 4.621 |
Enterprise Value (EV) 1 | 106.5 | 5.774 |
P/E ratio | -12.5 x | -0.47 x |
Yield | - | - |
Capitalization / Revenue | 24.5 x | 1.01 x |
EV / Revenue | 24.7 x | 1.27 x |
EV / EBITDA | -38.3 x | -1.85 x |
EV / FCF | -1,787,516,134 x | 7,228,089 x |
FCF Yield | -0% | 0% |
Price to Book | -31.6 x | -1.98 x |
Nbr of stocks (in thousands) | 44,686 | 51,342 |
Reference price 2 | 2.370 | 0.0900 |
Announcement Date | 01/04/22 | 11/05/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net sales 1 | 6.618 | 4.385 | 4.321 | 4.559 |
EBITDA 1 | -2.182 | -1.002 | -2.782 | -3.118 |
EBIT 1 | -2.635 | -1.432 | -3.21 | -5.023 |
Operating Margin | -39.82% | -32.66% | -74.29% | -110.18% |
Earnings before Tax (EBT) 1 | -2.841 | -1.728 | -7.111 | -8.537 |
Net income 1 | -2.791 | -0.9167 | -7.077 | -8.545 |
Net margin | -42.18% | -20.91% | -163.78% | -187.41% |
EPS 2 | -0.5200 | -0.1000 | -0.1900 | -0.1900 |
Free Cash Flow | - | 0.582 | -0.0596 | 0.7988 |
FCF margin | - | 13.27% | -1.38% | 17.52% |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 20/08/21 | 20/08/21 | 01/04/22 | 11/05/23 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net Debt 1 | 0.59 | 0.76 | 0.62 | 1.15 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | -0.2689 x | -0.7544 x | -0.2236 x | -0.3697 x |
Free Cash Flow | - | 0.58 | -0.06 | 0.8 |
ROE (net income / shareholders' equity) | - | -90.7% | 520% | 241% |
ROA (Net income/ Total Assets) | - | -16.5% | -37.4% | -62.9% |
Assets 1 | - | 5.557 | 18.92 | 13.59 |
Book Value Per Share 2 | 0.4400 | 0.1900 | -0.0800 | -0.0500 |
Cash Flow per Share 2 | 0.0500 | 0.0100 | 0.0200 | 0 |
Capex 1 | 0.05 | 0.01 | - | - |
Capex / Sales | 0.68% | 0.26% | - | - |
Announcement Date | 20/08/21 | 20/08/21 | 01/04/22 | 11/05/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+78.46% | 6.77M | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- STEK Stock
- Financials Stemtech Corporation